In a patient on hormone replacement therapy who reports irritability and is taking Lunesta (eszopiclone) for insomnia, what medication can be used to manage the irritability?

Address the Irritability First, Not Just the Sleep

The irritability in your patient on hormone replacement therapy (HRT) and Lunesta requires evaluation of whether it stems from the HRT itself, inadequate sleep despite Lunesta, or mood disturbance—and the treatment approach differs significantly based on this determination.

Clinical Algorithm for Management

Step 1: Determine the Source of Irritability

Evaluate these specific factors:

• Timing: Did irritability begin after starting HRT or Lunesta? Irritability can be a side effect of eszopiclone (Lunesta) itself 1
• Sleep quality: Is the patient actually sleeping well on Lunesta? Check for residual insomnia symptoms, early morning awakening, or daytime dysfunction
• HRT formulation: Progestins (especially medroxyprogesterone acetate) are more associated with mood symptoms than estradiol or progesterone 2
• Depression/anxiety screening: Irritability may signal underlying or emerging mood disorder that requires direct treatment

Step 2: Medication Options Based on Clinical Picture

If Irritability is Primarily Mood-Related (with or without adequate sleep):

First-line: Add an SSRI/SNRI that also addresses sleep

• Escitalopram 10 mg is specifically studied with eszopiclone cotherapy and showed significant improvements in both anxiety and mood symptoms 3, 4
• Venlafaxine (serotonin-norepinephrine reuptake inhibitor) has demonstrated efficacy for menopausal vasomotor symptoms AND mood symptoms 2
• Paroxetine is another option with data supporting use in menopausal symptoms 2

The combination of eszopiclone with escitalopram is well-tolerated, with the most common adverse events being unpleasant taste, headache, dry mouth, and somnolence 3. In patients with anxious depression and insomnia, this combination showed significantly greater improvements in depression scores and response rates compared to SSRI alone 4.

If Sleep Remains Inadequate Despite Lunesta:

Consider switching or augmenting the hypnotic:

According to AASM guidelines, the recommended sequence when initial hypnotic therapy fails is 5:

1. Switch to alternative benzodiazepine receptor agonist with different pharmacokinetics (e.g., if sleep maintenance is the issue, consider longer-acting agents)
2. Add low-dose sedating antidepressant: Trazodone, mirtazapine, or low-dose doxepin (3-6 mg) 5
   • Trazodone has minimal anticholinergic effects compared to other tricyclics 5
   • Doxepin 3-6 mg specifically improves total sleep time and wake after sleep onset 6
3. Combination therapy: BzRA + sedating antidepressant has extensive clinical experience supporting safety and efficacy 5

If HRT Formulation is Suspect:

Modify the HRT regimen:

• Switch from synthetic progestin (especially MPA) to micronized progesterone or norethindrone, which have more favorable mood profiles 2
• Consider transdermal estradiol over oral formulations 2
• Evaluate whether intermittent rather than continuous progestin administration reduces symptoms 2

Step 3: Specific Cautions with Current Lunesta Use

Important FDA warnings for eszopiclone 1:

• Complex behaviors (sleep-driving, sleep-eating) can occur, especially with alcohol or other CNS depressants
• Behavioral changes including aggressiveness, agitation, and depersonalization have been reported
• In patients with depression, worsening depression and suicidal ideation are possible
• Should be taken immediately before bed with 8 hours available for sleep

If adding another medication to Lunesta, dose adjustment may be necessary due to additive CNS-depressant effects 1.

Practical Recommendation

For a patient with irritability on HRT and Lunesta, I would:

1. Screen for depression/anxiety using validated tools (PHQ-9, GAD-7)
2. If mood symptoms are present: Add escitalopram 10 mg daily, which can be safely combined with eszopiclone and has specific evidence in this population 3, 4
3. If sleep is inadequate: Consider adding low-dose doxepin 3-6 mg or switching to a different hypnotic based on specific sleep complaint pattern 6
4. If HRT is suspect: Switch to estradiol with micronized progesterone or norethindrone 2
5. Avoid: Simply adding gabapentin, quetiapine, or other off-label agents without addressing the underlying cause, as evidence for these in primary insomnia is insufficient and side effect burden is significant 5

Common Pitfall to Avoid

Do not assume the irritability is solely a menopausal symptom requiring only HRT adjustment—it may represent emerging mood disorder, medication side effect, or inadequate sleep treatment. The combination of insomnia and mood symptoms requires addressing both simultaneously for optimal outcomes 3, 4, 7.